RDHL - RedHill Biopharma Revenue Dynamics YoY (Last Twelve Months)

Graphic logo of RedHill Biopharma Ltd (RDHL)

RedHill Biopharma (RDHL) has optimized the procurement of active components for GI therapy, eliminating supply chain disruptions. The year-over-year sales dynamics for the rolling period on the GURU.Markets daily price chart show that the current parameter is 0.00. Regional hubs ensure stability by enabling rapid delivery to clinics, while the business model relies on strict bioethics and the eco-friendly disposal of laboratory waste.

Sales Growth YoY (Last Twelve Months): RedHill (RDHL) for 02/11/2024 - 11/18/2026

RedHill Biopharma - analytical breakdowns and key metrics (RDHL)

- share price and expert price forecast:
Summary company analytics:redhillbio.com (RDHL)
Manufactured products of RedHill

As an Israeli biopharmaceutical player, RedHill Biopharma (RDHL) is exposed to geopolitical instability, which is mitigated by its global distribution network. This rolling annual sales volume indicator captures the actual TTM revenue dynamics, allowing investors to assess the resilience of cash flows to external shocks. Analyzing the amplitude of fluctuations on this chart helps differentiate the business model's adaptability from critical operational drawdown risks.